These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31804447)

  • 1. A Modeling-Based Approach to Estimate Fentanyl Pharmacokinetics in Obese Critically Ill Children.
    Tang C; Poloyac SM
    Pediatr Crit Care Med; 2019 Dec; 20(12):1208-1209. PubMed ID: 31804447
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children.
    Johnson PN; Skrepnek GH; Golding CL; Owora AH; Thomas AN; Miller JL
    Am J Health Syst Pharm; 2017 Aug; 74(15):1174-1183. PubMed ID: 28588011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of continuous infusions of fentanyl in critically ill children.
    Katz R; Kelly HW
    Crit Care Med; 1993 Jul; 21(7):995-1000. PubMed ID: 8319480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
    Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
    Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.
    Tse AHW; Ling L; Lee A; Joynt GM
    Clin Ther; 2018 Sep; 40(9):1598-1615.e2. PubMed ID: 30173953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion.
    Katz R; Kelly HW; Hsi A
    Crit Care Med; 1994 May; 22(5):763-7. PubMed ID: 8181283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients.
    Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Roger C; Udy AA; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.
    Jacqz-Aigrain E; Daoud P; Burtin P; Maherzi S; Beaufils F
    Eur J Clin Pharmacol; 1992; 42(3):329-32. PubMed ID: 1577053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug withdrawal symptoms in children after continuous infusions of fentanyl.
    French JP; Nocera M
    J Pediatr Nurs; 1994 Apr; 9(2):107-13. PubMed ID: 8027936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and the Risk of Under- and Overdosing.
    Jung B; Mahul M; Breilh D; Legeron R; Signe J; Jean-Pierre H; Uhlemann AC; Molinari N; Jaber S
    Crit Care Med; 2017 May; 45(5):e470-e478. PubMed ID: 28240688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl Pharmacokinetics in Critically Ill Patients: A Demonstration of Mixed Effects.
    Droege CA; Mueller EW
    Crit Care Med; 2016 Jan; 44(1):240-2. PubMed ID: 26672932
    [No Abstract]   [Full Text] [Related]  

  • 12. Population Pharmacokinetics of Fentanyl in the Critically Ill.
    Choi L; Ferrell BA; Vasilevskis EE; Pandharipande PP; Heltsley R; Ely EW; Stein CM; Girard TD
    Crit Care Med; 2016 Jan; 44(1):64-72. PubMed ID: 26491862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
    Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
    Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
    Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 genotype is associated with fentanyl requirements in critically ill children.
    Horvat CM; Au AK; Conley YP; Kochanek PM; Li L; Poloyac SM; Empey PE; Clark RSB
    Pediatr Res; 2017 Jul; 82(1):29-35. PubMed ID: 28388599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.
    Ross EL; Heizer J; Mixon MA; Jorgensen J; Valdez CA; Czaja AS; Reiter PD
    Am J Health Syst Pharm; 2015 Apr; 72(7):542-56. PubMed ID: 25788508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous propofol perfusion in critically ill children].
    Agudelo SC; Mencía S; Faro A; Escudero V; Sanavia E; López-Herce J
    Med Intensiva; 2012; 36(6):410-5. PubMed ID: 22244214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of exogenous epinephrine in critically ill children.
    Fisher DG; Schwartz PH; Davis AL
    Crit Care Med; 1993 Jan; 21(1):111-7. PubMed ID: 8420716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous caffeine in critically ill patients.
    Sánchez-Alcaraz A; Ibáñez P; Sangrador G
    J Clin Pharm Ther; 1991 Aug; 16(4):285-9. PubMed ID: 1939407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid withdrawal in critically ill neonates.
    Dominguez KD; Lomako DM; Katz RW; Kelly HW
    Ann Pharmacother; 2003 Apr; 37(4):473-7. PubMed ID: 12659598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.